FDA.reportPublic FDA data

ixekizumab 40 MG per 0.5 ML Prefilled Syringe

RxCUI
2674933
RxNorm name
ixekizumab 40 MG per 0.5 ML Prefilled Syringe
Display name
ixekizumab 40 MG per 0.5 ML Prefilled Syringe
Full name
ixekizumab 40 MG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125521Taltzixekizumab351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ac96658a-d7dc-4c7c-8928-2adcdf4318b2ixekizumab 40 MG per 0.5 ML Prefilled SyringeSY39These highlights do not include all the information needed to use TALTZ safely and effectively. See full prescribing information for TALTZ. TALTZ (ixekizumab) injection, for subcutaneous use Initial U.S. Approval: 201620241113
ac96658a-d7dc-4c7c-8928-2adcdf4318b20.5 ML ixekizumab 80 MG/ML Prefilled SyringeSCD39These highlights do not include all the information needed to use TALTZ safely and effectively. See full prescribing information for TALTZ. TALTZ (ixekizumab) injection, for subcutaneous use Initial U.S. Approval: 201620241113
ac96658a-d7dc-4c7c-8928-2adcdf4318b2ixekizumab 40 MG in 0.5 ML Prefilled SyringePSN39These highlights do not include all the information needed to use TALTZ safely and effectively. See full prescribing information for TALTZ. TALTZ (ixekizumab) injection, for subcutaneous use Initial U.S. Approval: 201620241113